We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cochlear Limited | ASX:COH | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -9.64 | -2.92% | 321.01 | 319.61 | 324.80 | 330.00 | 320.30 | 330.00 | 83,278 | 09:50:00 |
From May 2019 to May 2024
Swiss hearing aid maker Sonova Holdings AG (SOON.VX) plans to double sales of Advanced Bionics Corporation over the next three to five years, Chief Executive Valentin Chapero said Monday in a conference call.
"We also plan to increase the Ebita margin of Advanced Bionics to 20% or beyond in that period," he added.
In its fiscal year 2008, Advanced Bionics had sales of $117 million and a negative earnings before interest, taxes and amortization margin of 17%.
Earlier Monday, Sonova said it is buying US-based cochlear implant systems maker Advanced Bionics Corp. for $489 million, which was widely welcome by the market.
Sonova will report first-half figures for its 2010 fiscal year on Tuesday.
Company Web Site: http://www.sonova.com
-By Julia Mengewein, Dow Jones Newswires; +41 43 443 80 45; julia.mengewein@dowjones.com
1 Year Cochlear Chart |
1 Month Cochlear Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
